Development of novel gemcitabine-modified miRNA mimics for pancreatic ductal adenocarcinoma

被引:0
|
作者
Ju, Jingfang
机构
关键词
D O I
10.1158/1538-7445.PANCA2023-B076
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B076
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
    Shao, Feng
    Huang, Mei
    Meng, Futao
    Huang, Qiang
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [32] Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma
    Tada, Motohisa
    Ijichi, Hideaki
    Miyabayashi, Koji
    Saoka, Yoshinari A.
    Mohri, Dai
    Ikenoue, Tsuneo
    Mikata, Rintarou
    Tawada, Katsunobu
    Ishihara, Takeshi
    Kanai, Fumihiko
    Imazeki, Fumio
    Omata, Masao
    Moses, Harold L.
    Yokosuka, Osamu
    CANCER RESEARCH, 2012, 72
  • [33] Gemcitabine nanoparticles show in vitro efficacy in murine pancreatic ductal adenocarcinoma
    Tucci, Samantha T.
    Kakwere, Hamilton
    Kheirolomoom, Azadeh
    Seo, Jai W.
    Ingham, Elizabeth
    Hwang, Chang-Il
    Ferrara, Katherine
    CANCER RESEARCH, 2017, 77
  • [34] Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinoma
    Palam, L. R.
    Gore, J.
    Craven, K. E.
    Wilson, J. L.
    Korc, M.
    CELL DEATH & DISEASE, 2015, 6 : e1913 - e1913
  • [35] A Novel Endoglin Variant in Pancreatic Ductal Adenocarcinoma
    Kumar, Sanjay
    Shah, Nirav
    Zaman, Naveed
    Lee, Nam Y.
    FASEB JOURNAL, 2017, 31
  • [36] Development andIn VitroEvaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma
    Deodhar, S.
    Dash, A. K.
    North, E. J.
    Hulce, M.
    AAPS PHARMSCITECH, 2020, 21 (06)
  • [37] Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data
    Wang, Song
    Zhao, Yanxun
    Li, Dongsheng
    Zhu, Liangchen
    Shen, Zugang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02): : E226 - E233
  • [38] Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma
    S. Deodhar
    A. K. Dash
    E. J. North
    M. Hulce
    AAPS PharmSciTech, 21
  • [39] Integrated analysis of mRNA and miRNA expression profiles in pancreatic ductal adenocarcinoma
    Sun, Hongwei
    Zhao, Liang
    Pan, Kehua
    Zhang, Zhao
    Zhou, Mengtao
    Ca, Guoquan
    ONCOLOGY REPORTS, 2017, 37 (05) : 2779 - 2786
  • [40] Circadian Disruption in the Development of Pancreatic Ductal Adenocarcinoma
    Schwartz, P. B.
    Walcheck, M. T.
    Carrillo, N. D.
    Matkowskyj, K. A.
    Ronnekleiv-Kelly, S.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S189 - S189